tirzepatide liver enzymes Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic disease by reducing the expression of CD36 and OBP2A Tirzepatide Elevated Liver Enzymes

Why turkey sausage: Significantly lower in fat than pork sausage (which can worsen nausea), but still delivers that savory, satisfying breakfast taste

Whilst liraglutide primarily targets metabolic pathways rather than immune function, limited evidence exists specifically for autoimmune populations

We make it a better choice to start with Tirzepatide, BUT

The highest dose 1.2mg does match the weight loss curve of 5mg of tirzepatide, with around 14% loss but certainly not the higher doses of tirzepatide which were around 17-18% at 36 weeks

[1] [6] The MHRA approved tirzepatide in September 2022 for the treatment of type 2 diabetes mellitus in adults